SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-015459
Filing Date
2023-05-04
Accepted
2023-05-04 07:46:03
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-20230331.htm   iXBRL 10-Q 1570693
2 EX-31.1 cccc-20230331xexx311.htm EX-31.1 10468
3 EX-31.2 cccc-20230331xexx312.htm EX-31.2 10514
4 EX-32.1 cccc-20230331xexx321.htm EX-32.1 4845
5 EX-32.2 cccc-20230331xexx322.htm EX-32.2 4861
  Complete submission text file 0001628280-23-015459.txt   6281089

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20230331.xsd EX-101.SCH 42136
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cccc-20230331_cal.xml EX-101.CAL 75287
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cccc-20230331_def.xml EX-101.DEF 166164
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20230331_lab.xml EX-101.LAB 508460
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20230331_pre.xml EX-101.PRE 311512
58 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20230331_htm.xml XML 968060
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 23886567
SIC: 2836 Biological Products, (No Diagnostic Substances)